Improved Detection Sensitivity of an Antigen Test for SARS-CoV-2 Nucleocapsid Proteins with Thio-NAD Cycling
-
- Kyosei Yuta
- Department of Biology, Waseda University
-
- Namba Mayuri
- Department of Biology, Waseda University
-
- Yamura Sou
- Department of Biology, Waseda University
-
- Watabe Satoshi
- Waseda Research Institute for Science and Engineering, Waseda University
-
- Yoshimura Teruki
- School of Pharmaceutical Sciences, Health Sciences University of Hokkaido
-
- Sasaki Tadahiro
- Department of Viral Infections, Research Institute for Microbial Diseases, Osaka University
-
- Shioda Tatsuo
- Department of Viral Infections, Research Institute for Microbial Diseases, Osaka University
-
- Ito Etsuro
- Department of Biology, Waseda University Waseda Research Institute for Science and Engineering, Waseda University Graduate Institute of Medicine, Kaohsiung Medical University
Search this article
Description
<p>Antigen tests for infectious diseases are inexpensive and easy-to-use, but the limit of detection (LOD) is generally higher than that of PCR tests, which are considered the gold standard. In the present study, we combined a sandwich enzyme-linked immunosorbent assay (ELISA) with thionicotinamide-adenine dinucleotide (thio-NAD) cycling to improve the LOD of antigen tests for coronavirus disease 2019 (COVID-19). For recombinant nucleocapsid proteins of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the LOD of our ELISA with thio-NAD cycling was 2.95 × 10−17 moles/assay. When UV-irradiated inactive SARS-CoV-2 was used, the minimum detectable virions corresponding to 2.6 × 104 RNA copies/assay were obtained using our ELISA with thio-NAD cycling. The assay volume for each test was 100 µL. The minimum detectable value was smaller than that of the latest antigen test using a fluorescent immunoassay for SARS-CoV-2, indicating the validity of our detection system for COVID-19 diagnosis.</p>
Journal
-
- Biological and Pharmaceutical Bulletin
-
Biological and Pharmaceutical Bulletin 44 (9), 1332-1336, 2021-09-01
The Pharmaceutical Society of Japan
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390852182144963840
-
- NII Article ID
- 130008082348
-
- NII Book ID
- AA10885497
-
- ISSN
- 13475215
- 09186158
-
- NDL BIB ID
- 031643191
-
- PubMed
- 34148926
-
- Text Lang
- en
-
- Article Type
- journal article
-
- Data Source
-
- JaLC
- NDL Search
- Crossref
- PubMed
- CiNii Articles
- KAKEN
- OpenAIRE
-
- Abstract License Flag
- Disallowed